+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Premenstrual Syndrome Treatment Market by Drug Type, Type, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, by 2027

  • PDF Icon


  • 221 Pages
  • July 2023
  • Region: Global
  • IHR Insights
  • ID: 5850101
10% Free customization
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The premenstrual syndrome (PMS) treatment market refers to the market for products and therapies aimed at alleviating the symptoms associated with premenstrual syndrome. PMS is a common condition that affects women of reproductive age, typically occurring in the days or weeks leading up to menstruation. It is characterized by a range of physical and emotional symptoms, including mood swings, bloating, fatigue, irritability, and breast tenderness. Premenstrual Syndrome Treatment is likely to grow at a rate of 3.9% CAGR by 2027.

Premenstrual Syndrome Treatment Market, By Drug Type

  • Analgesics
  • Antidepressants

Oral Contraceptives & Ovarian Suppression Agents Premenstrual Syndrome Treatment Market, By Type

  • Prescription
  • OTC

Premenstrual Syndrome Treatment Market, By Distribution Channel

  • Hospital pharmacies
  • Drug stores & retail pharmacies
  • Online providers

Premenstrual Syndrome Treatment Market by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Here is an overview of the key aspects of the PMS treatment market:

On the basis of product type, the market is divided into Analgesics, Antidepressants and Oral Contraceptives & Ovarian Suppression Agents. The modified silicone fluid has the highest share in the market. This is due to the increased adoption of analgesics as first line treatment for the management of PMS.

The type segment is bifurcated into prescription and OTC where OTC segment holds the significant share in the market. Since, the most of the consumers prefer OTC medicines to relief pain.

As per the distribution channel, the market is classified into Hospital pharmacies, Drug stores & retail pharmacies and Online providers. The online providers segment is likely to show major growth due to the increase in online purchases.

Medications: Various over-the-counter and prescription medications are available to manage PMS symptoms. Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, can help relieve pain, cramping, and inflammation. Selective serotonin reuptake inhibitors (SSRIs), typically used as antidepressants, may also be prescribed to regulate mood and reduce emotional symptoms associated with PMS.

Hormonal Therapies: Hormonal therapies are sometimes used to address hormonal imbalances which contribute to PMS symptoms. Oral contraceptives, containing a combination of estrogen and progestin, can help regulate hormone levels and alleviate symptoms. Other hormonal treatments, such as gonadotropin-releasing hormone (GnRH) agonists or antagonists, may be considered in severe cases.

Nutritional Supplements: Certain dietary supplements and natural remedies are used to manage PMS symptoms. These may include calcium, magnesium, vitamin B6, and herbal supplements like chasteberry (vitex agnus-castus), evening primrose oil, or black cohosh. However, the scientific evidence supporting the effectiveness of these supplements in relieving PMS symptoms is mixed.

Lifestyle Changes: Lifestyle modifications can play a significant role in managing PMS symptoms. Regular exercise, a balanced diet, stress reduction techniques, and adequate sleep are commonly recommended. Avoiding caffeine, alcohol, and salty foods may also help reduce symptoms such as bloating and breast tenderness.

Psychological Support: Psychological support, such as cognitive-behavioral therapy (CBT) or counseling, can be beneficial for managing emotional symptoms associated with PMS. These therapies help individuals develop coping strategies, improve mood regulation, and address any underlying psychological factors contributing to PMS symptoms.

Market Trends: The PMS treatment market is witnessing a growing demand for personalized and holistic approaches. There is increasing interest in natural and integrative therapies, including herbal remedies and mind-body techniques. Additionally, advancements in technology have facilitated the development of mobile applications and wearable devices that help individuals track their symptoms, identify patterns, and manage their condition more effectively.

It's important to note that the effectiveness of PMS treatments can vary among individuals, and what works for one person may not work for another. It is recommended that individuals consult with healthcare professionals to discuss their symptoms and determine the most appropriate treatment options for their specific need.

The leading players of the market are ABBVIE INC., AstraZeneca plc, BASF Corporation, Bayer AG., Dr. Reddy’s Laboratories Ltd, Eli Lilly And Company., GlaxoSmithKline Plc., H. Lundbeck A/S, Pfizer Inc., Shionogi Inc.

The report analyzes the geographical highlights in terms of consumption of the product/service within the region also indicates the factors which are affecting the market within each

Table of Contents

1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Drug Type: Market Size & Analysis
5.1. Analgesics
5.2. Antidepressants
5.3. Oral Contraceptives & Ovarian Suppression Agents
6. Type: Market Size & Analysis
6.1. Prescription
6.2. OTC
7. Distribution Channel: Market Size & Analysis
7.1. Hospital Pharmacies
7.2. Drug Stores & Retail Pharmacies
7.3. Online pharmacies
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
10.1. AbbVie INC.
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. AstraZeneca plc.
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. Bayer AG
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. BASF Corporation
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. Dr. Reddy’s Laboratories Ltd
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. Eli Lilly And Company
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. GlaxoSmithKline Plc
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. H. Lundbeck A/S
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. Pfizer Inc
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. Shionogi Inc.
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. Analyst Opinion
12. Annexure
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations

Companies Mentioned

  • AbbVie INC.
  • AstraZeneca plc.
  • Bayer AG
  • BASF Corporation
  • Dr. Reddy’s Laboratories Ltd
  • Eli Lilly And Company
  • GlaxoSmithKline Plc
  • H. Lundbeck A/S
  • Pfizer Inc
  • Shionogi Inc.